Skip to main content

Neuroscience Startups

Updated October 2026

Companies in the neuroscience sector developing innovative solutions and technologies.

Explore 339 recently funded neuroscience companies with verified founder contact information and fundraising data.

Total Companies
339
Total Funding
$817.5M
Avg Funding
$32.7M
Global Reach
8
countries

Top Cities for Neuroscience

Sydney
Epalinges
Delft
Whitefish
Cambridge
Seattle

Recently Funded Companies

Export
Sydney, Australia

Omniscient develops AI and data-driven solutions to improve treatment for brain disorders, providing predictive analytics for clinicians.

$13.4M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Epalinges, Switzerland

Emovo Care develops robotic accessible devices to bring movement home for people with motor impairments

$112K raised
Nov 2025

Founder Contacts

41,000+ verified contacts

Delft, The Netherlands

Zander Labs develops neuroadaptive AI that learns directly from the human brain, using passive Brain-Computer Interface by non-invasive EEG.

$866K raised
Jan 2023

Founder Contacts

41,000+ verified contacts

Whitefish, United States

Neuro-ID provides behavioral analytics identity solutions for banks, fintech, and insurance industries.

$35.0M raised
Nov 2021

Founder Contacts

41,000+ verified contacts

Cambridge, United Kingdom

Coherence develops healthcare tech linking cancer neuroscience with neurotechnology for new treatments.

$10.0M raised
Nov 2025

Founder Contacts

41,000+ verified contacts

Seattle, United States

Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease.

$96.0M raised
Nov 2022

Founder Contacts

41,000+ verified contacts

San Diego, United States

Escient Pharmaceuticals is a privately-held biotechnology company focusing on the advancement of G Protein-Coupled Receptor targeted drugs.

$120.0M raised
Nov 2022

Founder Contacts

41,000+ verified contacts

Castejón De Sos, Spain

We develop Algorithmic - Artificial General Intelligence (A-AGI), human-like intelligent autonomous systems. XAI (ETR 0.5). SaaS/API/Edge

$35K raised
Jan 2026

Founder Contacts

41,000+ verified contacts

St. John's, Canada

AI-powered digital health platform revolutionizing motor symptom assessment in Parkinson’s and neurological care.

$35K raised
Jan 2025

Founder Contacts

41,000+ verified contacts

Boston, United States

Lusaris Therapeutics develops small-molecule neuroplastogen therapeutics for neuropsychiatric and neurological disorders.

$60.0M raised
Nov 2022

Founder Contacts

41,000+ verified contacts

Excelsior, United States

EmpowerU engages struggling students in their wellness journey through social-emotional learning lessons and coaching support.

Jan 2022

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Bringing neuromodulation therapeutics from the hospital, to the home of the patients.

$500K raised
Jan 2022

Founder Contacts

41,000+ verified contacts

Paris, France

Wisear enables people to get high-speed, private & inclusive controls over their everyday devices

$1.3M raised
Jan 2022

Founder Contacts

41,000+ verified contacts

San Diego, United States

Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies and autologous regenerative medicine.

$115.0M raised
Nov 2025

Founder Contacts

41,000+ verified contacts

San Diego, United States

Cortica provides neurological therapies for children with autism and other developmental differences.

$80.0M raised
Nov 2024

Founder Contacts

41,000+ verified contacts

San Diego, United States

Health Tech company driven by AI, machine learning, and biometrics in 133 countries serving USAF and others.

$498K raised
Nov 2024

Founder Contacts

41,000+ verified contacts

Plan-les-ouates, Switzerland

Ovomind proposes a new way to share and interact with video games by adding a new dimension - emotions.

$62K raised
Nov 2025

Founder Contacts

41,000+ verified contacts

Cambridge, United States

nQ Medical is a neurotechnology company allowing Data Defined Disease Management via digital biomarkers using AI.

Nov 2021

Founder Contacts

41,000+ verified contacts

Mountain View, United States

A neuro-inspired ecosystem of intelligent systems to reduce clinical staff requirements, improve patient satisfaction, and increase revenue.

$850K raised
Nov 2023

Founder Contacts

41,000+ verified contacts

Bloomington, United States

Saluda Medical is a commercial-stage medical device company that develops treatments for chronic neurological conditions.

$30.0M raised
Nov 2025

Founder Contacts

41,000+ verified contacts

New Haven, United States

Biohaven is a biopharmaceutical company that develops drug candidates targeting neurological diseases.

$200.0M raised
Nov 2025

Founder Contacts

41,000+ verified contacts

Basel, Switzerland

Indivi develops functional biomarkers that measure key disability concepts of importance for drug development trials in neuroscience

$18.8M raised
Nov 2025

Founder Contacts

41,000+ verified contacts

London, United Kingdom

Kneu Health transforms smart phones into clinical-grade monitors to keep a tab on neurological conditions like Parkinson’s and dementia.

$5.6M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Valencia, Spain

Neuronoff is a medical device developing comapny.

$4.5M raised
Oct 2025

Founder Contacts

41,000+ verified contacts

Carmel, United States

Gate Neurosciences is a healthcare company that offers neuroscience-related medical services.

$25.0M raised
Oct 2022

Founder Contacts

41,000+ verified contacts

Showing 301 to 325 of 339 companies

About the Neuroscience Startup Ecosystem

The neuroscience sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Neuroscience

Neuroscience companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The neuroscience sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Neuroscience Funding Breakdown

Here is how funding is distributed among the 339 neuroscience companies tracked in the VCBacked database.

Average Funding
$32.7M
Total Funding Tracked
$817.5M
Countries Represented
8

Distribution by Funding Stage

Other25 companies

Top Cities for Neuroscience

1.San Diego
4 companies$315.5M
2.Cambridge
3 companies$10.5M
3.Sydney
1 companies$13.4M
4.Epalinges
1 companies$112K
5.Delft
1 companies$866K

Related Industries

Companies in the neuroscience sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Neuroscience Startups?

Perfect for: B2B sales teams targeting neuroscience companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked